All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

BREAKING: Peer-Reviewed Study Finds mRNA, SV40, and Spike Protein Can Persist in Humans for At Least 3.5 Years After COVID-19 "Vaccination"

We report the longest documented persistence of COVID-19 vaccine-derived material to date following YEARS of investigation spanning 200+ specialist evaluations and 200+ advanced lab/imaging tests.

Read the full article

You might also wanna read

Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes

The timeline to develop coronavirus vaccines blew many predictions out of the water.

clinicaltrialsabundance.blog·13d ago

Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes

The timeline to develop coronavirus vaccines blew many predictions out of the water.

clinicaltrialsabundance.blog·13d ago

Lancet Review Confirms mRNA COVID-19 Vaccines Are Safe, Effective, and Paving the Way for Cancer Treatments

Learn how mRNA vaccines work, why serious risks remain rare, and how the technology could be used beyond COVID-19.

discovermagazine.com·7d ago

Does COVID-19 Survive in Refrigerated Conditions? Exploring the Facts

The question of whether COVID-19 can survive refrigeration is a critical one, especially in the context of food safety, laboratory research,

cycookery.com

Study Examines Association Between mRNA COVID-19 Vaccination and 4-Year All-Cause Mortality in French Adults Aged 18-59

This cohort study uses the data from all adults aged 18 to 59 years living in France on November 1, 2021, to evaluate whether there is an as

jamanetwork.com·7mo ago

Study: Metformin During Acute COVID Shows Mixed Results for Preventing Long COVID

Early metformin treatment in mild-to-moderate COVID may not prevent long-term symptoms but is linked to relatively fewer clinician-diagnosed

mdsc.pe·9d ago

Moderna's combined flu and COVID-19 mRNA vaccine shows durable immune response in mid-stage trial

A single dose of mRNA-1073 elicited durable immune responses through 6 months against all vaccine-matched influenza and SARS-CoV-2 strains.

cidrap.umn.edu·26d ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.